Evidence map›Paper›PMID 21976503›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion.

Melissa W VonDran, Harmandeep Singh, Jean Z Honeywell, Cheryl F Dreyfus

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 143 citations in OpenAlex.

  1. Article
  2. Review
  3. Generation of xenobiotic free retinofugal assembloids.Frontiers in cell and developmental biology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Melissa W VonDranDepartment of Neuroscience and Cell Biology, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
Harmandeep Singh
Jean Z Honeywell
Cheryl F Dreyfus
Rutgers, The State University of New Jersey · US

Funding

THE ROLE OF NEUROTROPHINS IN OLIGODENDROCYTE FUNCTION (Administrative Supplement)R01NS036647 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI DREYFUS, CHERYL F · 1998 to 2019
$4.9M
The Role of Neurotrophins in Oligodendrocyte FunctionR56NS036647 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI DREYFUS, CHERYL F · 2007 to 2007
$350k
NINDS NIH HHS NS036647NINDS NIH HHS R01 NS036647NINDS NIH HHS R56 NS036647
6 · The paper itself

Abstract

Previous work in culture has shown that basal forebrain (BF) oligodendrocyte (OLG) lineage cells respond to BDNF by increasing DNA synthesis and differentiation. Further, in the BF in vivo, reduced levels of BDNF as seen in BDNF(+/-) mice result in reduced numbers of NG2+ cells and deficits in myelin proteins throughout development and in the adult, suggesting that BDNF impacts the proliferating population of OLGs as well as differentiation in vivo. In this study, to investigate the roles BDNF may play in the repair of a demyelinating lesion, the cuprizone model was used and the corpus callosum was examined. BDNF protein levels were reduced after cuprizone treatment, suggesting that the demyelinating lesion itself elicits a decrease in BDNF. To analyze the effects of a further reduction of BDNF on OLG lineage cells following cuprizone, BDNF(+/-) mice were evaluated. These mice exhibited a blunted increase in the NG2 response at 4 and 5 weeks of cuprizone treatment. In addition, BDNF(+/-) mice exhibited decreased levels of myelin proteins during the demyelination and remyelination processes with no change in the total number of OLGs. These effects appear to be relatively specific to OLG lineage cells as comparable changes in CD11b+ microglia, GFAP+ astrocytes, and SMI32+ injured axons were not observed. These data indicate that BDNF may play a role following a demyelinating lesion by regulating the numbers of progenitors and the abilities of demyelinating and differentiating cells to express myelin proteins.

Indexed as

AnimalsBrain-Derived Neurotrophic FactorCell CountCell LineageCells, CulturedChelating AgentsCorpus CallosumCuprizoneMaleMiceMice, 129 StrainMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicMyelin ProteinsOligodendrogliaBrain-Derived Neurotrophic FactorChelating AgentsCuprizoneMyelin Proteins

Identifiers

PMID21976503
PMCPMC3203635
OpenAlexW2075671660

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.